Role of edema in peritumoral cyst formation.
暂无分享,去创建一个
John A Butman | E. Oldfield | J. Butman | R. Lonser | Edward H Oldfield | Russell R Lonser | Martin A Baggenstos | M. Baggenstos
[1] Michael A. Finn,et al. Edema is a precursor to central nervous system peritumoral cyst formation , 2005, Annals of neurology.
[2] L. Aiello,et al. Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416. , 2002, Ophthalmology.
[3] W. Reinhold,et al. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. , 1993, The Journal of clinical investigation.
[4] R. R. Lonser,et al. von Hippel-Lindau disease , 2003, The Lancet.
[5] T. Shawker,et al. Elucidating the pathophysiology of syringomyelia. , 1999, Journal of neurosurgery.
[6] J. Moringlane,et al. Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis? , 1994, Neurosurgery.
[7] John A Butman,et al. Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion. , 2002, Journal of neurosurgery.
[8] R K Jain,et al. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. , 1988, Cancer research.
[9] E. Oldfield,et al. Pathogenesis of tumor-associated syringomyelia demonstrated by peritumoral contrast material leakage. Case illustration. , 2006, Journal of neurosurgery. Spine.
[10] R. Liščák,et al. Low-grade gliomas treated by fractionated gamma knife surgery. , 2005, Journal of neurosurgery.
[11] P F Morrison,et al. Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. , 1995, Journal of neurosurgery.
[12] S. Richard,et al. Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas. , 2003, American journal of ophthalmology.
[13] P F Morrison,et al. Convection-enhanced delivery of macromolecules in the brain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Qin,et al. Effect of brain irradiation on blood-CSF barrier permeability of chemotherapeutic agents. , 1997, American journal of clinical oncology.
[15] H. Wurzer,et al. Analysis of Fluid in Cysts Accompanying Various Primary and Metastatic Brain Tumours: Proteins, Lactate and pH , 1998, Acta Neurochirurgica.
[16] Christopher J. Brown,et al. Evidence for rapid fluid flow from the subarachnoid space into the spinal cord central canal in the rat , 1996, Brain Research.
[17] T. Nose,et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. , 1996, Cancer research.
[18] R T Borchardt,et al. Vascular endothelial growth factor affects permeability of brain microvessel endothelial cells in vitro. , 1996, The American journal of physiology.
[19] E. Oldfield,et al. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. , 2003, Journal of neurosurgery.
[20] T. Merchant,et al. Effects of fractionated radiation on the brain vasculature in a murine model: blood-brain barrier permeability, astrocyte proliferation, and ultrastructural changes. , 2006, International journal of radiation oncology, biology, physics.
[21] E. Papavassiliou,et al. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. , 1996, The Journal of clinical investigation.
[22] K. Gwan Go,et al. The Pathogenesis of Cysts Accompanying Intra-axial Primary and Metastatic Tumors of the Central Nervous System , 1998, Journal of Neuro-Oncology.
[23] Barry W Wessels,et al. Safety and Feasibility of Convection-enhanced Delivery of Cotara for the Treatment of Malignant Glioma: Initial Experience in 51 Patients , 2005, Neurosurgery.
[24] R. Weil,et al. Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. , 2003, Journal of neurosurgery.
[25] Yue Cao,et al. Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] G J Murray,et al. Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease , 2007, Neurology.
[27] C. Palmer,et al. Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. , 1997, Neurosurgery.
[28] K. Ohtomo,et al. Gamma knife surgery for hemangioblastomas. , 2005, Journal of neurosurgery.
[29] Tracy T Batchelor,et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. , 2007, Cancer cell.
[30] M. Berger,et al. Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors , 2003, Journal of Neuro-Oncology.
[31] Y. Mori,et al. Gamma knife radiosurgery for low-grade astrocytomas: results of long-term follow up. , 2000, Journal of neurosurgery.
[32] S. Coca,et al. Vascular Permeability Factor Expression in Cerebellar Hemangioblastomas: Correlation with Tumor-associated Cysts , 2004, Journal of Neuro-Oncology.
[33] Mitchel S Berger,et al. Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies. , 2006, Neurosurgical focus.
[34] K. Hemminki,et al. Familial risks in nervous system tumors. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[35] A. Holodny,et al. MRI of high-grade glial tumors: correlation between the degree of contrast enhancement and the volume of surrounding edema , 1997, Neuroradiology.
[36] E. Oldfield,et al. Direct convective delivery of macromolecules to the spinal cord. , 1998, Journal of neurosurgery.
[37] O. R. Blaumanis,et al. Evidence for a ‘Paravascular’ fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space , 1985, Brain Research.
[38] T. Merchant,et al. Rd permeability and leukocyte adhesion in the rat blood-brain barrier: modulation with anti-ICAM-1 antibodies , 2003 .
[39] D. Áfra,et al. Cysts in malignant gliomas. Identification by computerized tomography. , 1980, Journal of neurosurgery.
[40] H. van Mameren,et al. On the pathogenesis of brain tumour cysts: a volumetric study of tumour, oedema and cyst , 2000, Neuroradiology.
[41] A. Kalnin,et al. Correlation between the degree of contrast enhancement and the volume of peritumoral edema in meningiomas and malignant gliomas , 1999, Neuroradiology.
[42] Susan M. Chang,et al. Dynamic susceptibility contrast perfusion imaging of radiation effects in normal‐appearing brain tissue: Changes in the first‐pass and recirculation phases , 2005, Journal of magnetic resonance imaging : JMRI.
[43] U Klose,et al. Role of hydrodynamic processes in the pathogenesis of peritumoral brain edema in meningiomas. , 2000, Journal of neurosurgery.
[44] J. Boëthius,et al. Gamma knife radiosurgery for pilocytic astrocytomas. , 2002, Journal of neurosurgery.
[45] H. Dvorak,et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.
[46] E. Blaauw,et al. The pathogenesis of cerebral gliomatous cysts. , 1992, Neurosurgery.
[47] R. Sestini,et al. Genetic insights into familial tumors of the nervous system , 2004, American journal of medical genetics. Part C, Seminars in medical genetics.
[48] J. Bruce,et al. Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone. , 1987, Journal of neurosurgery.
[49] T H Shawker,et al. Pathophysiology of syringomyelia associated with Chiari I malformation of the cerebellar tonsils. Implications for diagnosis and treatment. , 1994, Journal of neurosurgery.
[50] M. Toi,et al. Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications. , 2001, The Lancet. Oncology.
[51] A. Obwegeser,et al. Vascular endothelial growth factor (VEGF) is elevated in brain tumor cysts and correlates with tumor progression , 2000, Acta Neuropathologica.
[52] R. Weil,et al. Surgical management of brainstem hemangioblastomas in patients with von Hippel-Lindau disease. , 2008, Journal of neurosurgery.
[53] Y. Kakuta,et al. Cyst formation following gamma knife surgery for intracranial meningioma. , 2005, Journal of neurosurgery.
[54] Y. Song,et al. Improved efficacy of chemotherapy for glioblastoma by radiation-induced opening of blood-brain barrier: clinical results. , 2001, International journal of radiation oncology, biology, physics.
[55] J. Jääskeläinen,et al. Gamma knife radiosurgery in 11 hemangioblastomas. , 1996, Journal of neurosurgery.
[56] H. Wurzer,et al. Cystic lesions accompanying extra-axial tumours , 1999, Neuroradiology.
[57] E. Oldfield,et al. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors , 1997, Nature Medicine.
[58] Ted,et al. Address Reprint Requests To , 2008 .
[59] A. Vortmeyer,et al. Proteomic analysis of hemangioblastoma cyst fluid , 2006, Cancer biology & therapy.